Stock earnings page

Neuronetics, Inc. (STIM)

Track the next or latest earnings date for Neuronetics, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

Is Summit’s Ivonescimab Oncology Bet Reshaping The Investment Case For Summit Therapeutics (SMMT)? - Simply Wall St News
simplywall.st · 2 days ago

In recent months, Summit Therapeutics has drawn attention for advancing ivonescimab, a bispecific antibody in late-stage development for non-small cell lung cancer and colorectal cancer, while remaining unprofitable and continuing to post negative earnings. The company’s heavy R&D investment ...

Neuronetics 10% owner Chernett buys $117,000 in common stock By Investing.com
www.investing.com · 2 days ago

Following this direct acquisition, ... as the stock trades near $1.20, down 72% over the past year. According to InvestingPro analysis, the company appears undervalued at current levels—a view that may align with Chernett’s decision to increase his stake. Investors seeking deeper insights can access…

Bernstein downgrades Summit Therapeutics stock rating on trial concerns By Investing.com
investing.com · 1 day ago

Bernstein downgrades Summit Therapeutics stock rating on trial concerns

Insider Buying: Jorey Chernett Acquires 100,000 Shares of Neuronetics Inc (STIM)
www.gurufocus.com · 2 days ago

GuruAI Model Portfolios All-In-One ... Calendar Earnings Calendar & Reports Analyst Ratings Embed Widgets Stock Market Holidays Transcripts Search ... Chat Support Create a ticket User Engagement Meeting 469-248-6885 Status Take Survey Give us your feedback ... Jorey Chernett, a 10% Owner, recently …

STMicroelectronics stock hits 52-week high at 65.34 USD By Investing.com
investing.com · 1 day ago

Mizuho previously noted ... and earnings per share of $0.13, with guidance for June quarter revenue exceeding consensus estimates. These developments underscore the company’s strong performance and potential for future growth. This article was generated with the support of AI and reviewed by an edit…

Latest earnings date

Mar 17, 2026

Time not specified

Fiscal quarter: 2025-12-31

EPS estimate: -$0.12

Revenue estimate: N/A

Market cap: $83.90M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Mar 17, 2026	2025-12-31	Time not specified	-$0.12	N/A